Your browser doesn't support javascript.
loading
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.
Montico, B; Lapenta, C; Ravo, M; Martorelli, D; Muraro, E; Zeng, B; Comaro, E; Spada, M; Donati, S; Santini, S M; Tarallo, R; Giurato, G; Rizzo, F; Weisz, A; Belardelli, F; Dolcetti, R; Dal Col, J.
Afiliación
  • Montico B; Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy.
  • Lapenta C; Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy.
  • Ravo M; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi (SA), Italy.
  • Martorelli D; Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy.
  • Muraro E; Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy.
  • Zeng B; The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Comaro E; Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy.
  • Spada M; Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy.
  • Donati S; Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy.
  • Santini SM; Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy.
  • Tarallo R; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi (SA), Italy.
  • Giurato G; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi (SA), Italy.
  • Rizzo F; Genomix4Life srl, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi (SA), Italy.
  • Weisz A; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi (SA), Italy.
  • Belardelli F; Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi (SA), Italy.
  • Dolcetti R; Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy.
  • Dal Col J; Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy.
Oncoimmunology ; 6(11): e1356964, 2017.
Article en En | MEDLINE | ID: mdl-29147614

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Oncoimmunology Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Oncoimmunology Año: 2017 Tipo del documento: Article País de afiliación: Italia